Thank you for donating!

You can donate using the following services.

Posts filed in: "Vtesse"

  1. 30.01.19

    Orphazyme reports positive results from full data set of Phase II/III arimoclomol trial in Niemann-Pick disease Type C (NPC)

    We are pleased to share the latest update from Orphazyme entitled 'Orphazyme reports positive results from full data set of Phase II/III arimoclomol trial in Niemann-Pick disease Type C (NPC)'.

    Read more
  2. 11.01.19

    CTD Announces Presentation at Upcoming Conference on Lysosomal Storage Diseases

    CTD Holdings: Annual conference offers opportunities for academic researchers and industry representatives to exchange information on novel therapeutic interventions...

    Read more
  3. 08.01.19

    Sanofi Genzyme: ASCEND and ASCEND-Peds Studies Complete Enrollment

    Sanofi Genzyme’s Global Project Team would like to announce that our pivotal registration study (ASCEND Study) for adult patients with chronic, systemic acid sphingomyelinase deficiency (ASMD) Types B and A/B (or intermediate type) and our pediatric study (ASCEND-Peds) also treating Type B and A/B ASMD pediatric patients have successfully completed enrollment for the targeted number of patients for each of these trials...

    Read more
  4. 11.12.18

    Orphazyme expects to announce results of full data set for Niemann-Pick disease Type C (NPC) Phase II/III trial in Q1 2019

    Orphazyme expects to announce results of full data set for Niemann-Pick disease Type C (NPC) Phase II/III trial in Q1 2019...

    Read more
  5. 30.11.18

    Mallinckrodt Responds to Global Community Questions on VTS-270 Trial

    Read more